AR and breast cancer: Androgen receptors (AR) are expressed in most BC, and AR positivity (nuclear staining by immunohistochemistry (IHC) in 10% or more of cells) was observed in 77% of 3093 invasive breast tumors of all subtypes, including 91% of ER+ BC2.